GGrantIndex
← Leaderboards

Kirk A Frey

University Of Michigan At Ann Arbor

$5,028,153
Attributed
$5,187,425
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY200522
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$18,189,474 · 7

By mechanism

P01$13,680,475 · 4
U01$3,966,967 · 1
R21$318,545 · 1
P50$223,487 · 1

Top collaborators

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Dementia

Research focus

DementiaPositron-Emission TomographyNeurochemistryDopamineAlzheimer&AposMichiganImageBrainAutopsyProgramsParkinson DiseaseS DiseaseBaseCognitiveNerve DegenerationNeuronsTau ProteinsAmyloid DepositionDopaminergic NeuronAmyloidCognitive DeficitsFollow-UpNeocorticalCorpus Striatum Structure

Grant awards (33)

Lewy Body Dementia Biomarkers$768,184
U01 · FY2022 · NS · contact PI
Lewy Body Dementia Biomarkers$768,184
U01 · FY2021 · NS · contact PI
Clinical MAO PET Imaging via Trapped Metabolites$318,545
R21 · FY2021 · AG
Lewy Body Dementia Biomarkers$410,661
U01 · FY2019 · NS · contact PI
Lewy Body Dementia Biomarkers$1,056,529
U01 · FY2017 · NS · contact PI
Lewy Body Dementia Biomarkers$963,409
U01 · FY2016 · NS · contact PI
PET Study of Biochemistry and Metabolism of the CNS$1,258,085
P01 · FY2012 · NS · contact PI
Cognitive Impairment and Decline in Parkinson Disease$81,615
P01 · FY2012 · NS · contact PI
Administration$52,625
P01 · FY2012 · NS · contact PI
PET Study of Biochemistry and Metabolism of the CNS$1,258,085
P01 · FY2011 · NS · contact PI
Cognitive Impairment and Decline in Parkinson Disease$81,615
P01 · FY2011 · NS · contact PI
Administration$52,625
P01 · FY2011 · NS · contact PI
PET Study of Biochemistry and Metabolism of the CNS$1,258,100
P01 · FY2010 · NS · contact PI
Cognitive Impairment and Decline in Parkinson Disease$86,126
P01 · FY2010 · NS · contact PI
Administration$52,626
P01 · FY2010 · NS · contact PI
PET Study of Biochemistry and Metabolism of the CNS$1,270,808
P01 · FY2009 · NS · contact PI
Cognitive Impairment and Decline in Parkinson Disease$82,440
P01 · FY2009 · NS · contact PI
Administration$53,157
P01 · FY2009 · NS · contact PI
PET Study of Biochemistry and Metabolism of the CNS$1,270,807
P01 · FY2008 · NS · contact PI
Cognitive Impairment and Decline in Parkinson Disease$82,440
P01 · FY2008 · NS · contact PI
Administration$53,157
P01 · FY2008 · NS · contact PI
PET Study of Biochemistry and Metabolism of the CNS$1,413,686
P01 · FY2005 · NS
PET Study of Biochemistry and Metabolism of the CNS$1,376,812
P01 · FY2004 · NS
PET Study of Biochemistry and Metabolism of the CNS$1,336,834
P01 · FY2003 · NS
PET Study of Biochemistry and Metabolism of the CNS$1,298,923
P01 · FY2002 · NS
PRESYNAPTIC NEUROCHEMICAL MARKERS$0
P50 · FY2002 · AG
PRESYNAPTIC NEUROCHEMICAL MARKERS$0
P50 · FY2002 · AG
STRIATAL DOPAMINE /MOTOR PERFORMANCE /AGING &PARKINSONS$0
P01 · FY2002 · NS
PET Study of Biochemistry and Metabolism of the CNS$1,259,909
P01 · FY2001 · NS
PRESYNAPTIC NEUROCHEMICAL MARKERS$0
P50 · FY2001 · AG
PRESYNAPTIC NEUROCHEMICAL MARKERS$0
P50 · FY2001 · AG
STRIATAL DOPAMINE /MOTOR PERFORMANCE /AGING &PARKINSONS$0
P01 · FY2001 · NS
PRESYNAPTIC NEUROCHEMICAL MARKERS$223,487
P50 · FY2000 · AG